Intrathecal Morphine vs. US-Guided Bilateral Posterior Quadratus Lumborum Block in Cesarean Section

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

68 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-03

Study Completion Date

2024-12-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, it was aimed to evaluate the effects of intrathecal morphine and posterior quadratus lumborum block (QLB2) on postoperative acute pain scores and opioid consumption in the first 24 hours after cesarean section.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Quadratus Lumborum Block vs Intrathecal Morphine for Post-Cesarean Analgesia

NCT06612424

Postoperative Pain

COMPLETED NA

Comparison of the Effects of QLB 2 and QLB 3 on Post-operative Analgesia in Cesarean Section Surgery

NCT04364906

Analgesia Acute Pain Chronic Pain

COMPLETED NA

Comparison of the Effects of TFPB and Anterior QLB on Postoperative Analgesia in Cesarean Section Surgery

NCT05408403

Analgesia Acute Pain Chronic Pain

COMPLETED NA

Effect of Quadratus Lumborum Block in C/S

NCT04733313

Postoperative Pain Cesarean Section Complications Block +1 more

COMPLETED NA

Ultrasound Guided QLB III Versus Intrathecal Morphine for Analgesia After Cesarean Section

NCT03428880

Block

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postoperative acute pain following a cesarean section is sharp, well-localized, and highly intense. An ideal pain management approach after a cesarean section should provide high-quality analgesia with minimal side effects and facilitate the mother's rapid return to daily activities. Different options for pain control include central blocks, peripheral blocks, and systemic medications.

Intrathecal morphine (ITM) administration is a widely used approach for post-cesarean pain management both globally and in our clinic. However, it can reduce patient satisfaction due to side effects such as nausea, vomiting, and itching. On the other hand, the Quadratus Lumborum Block (QLB), a type of peripheral block, has proven analgesic efficacy in controlling acute postoperative pain following a cesarean section. The aim of this study is to examine and compare the analgesic efficacy of intrathecal morphine (ITM) and Posterior Quadratus Lumborum in the management of acute postoperative pain after a cesarean section.

This study is a single-center, double-blind, prospective observational study.

Patients will be divided into 2 groups.

Group 1: The group receiving intrathecal morphine (ITM)

Group 2: The group receiving Posterior Quadratus Lumborum Block

In elective cesarean section cases under spinal anesthesia, the patient group receiving ITM and posterior QLB will be evaluated for obstetric general well-being during the first 24 hours and at discharge. Total morphine consumption in the first 24 hours, Pain scores (NRS) at rest and during movement, presence of nausea-vomiting and itching, patient satisfaction and any potential side effects will be recorded through follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intrathecal Morphine

A subarachnoid block will be performed by injecting morphine 100 mcg + 12.5 mg hyperbaric bupivacaine + 20 mcg fentanyl.

Intrathecal Morphine (ITM)

Intervention Type PROCEDURE

morphine 100 mcg + 12.5 mg bupivacaine + 20 mcg fentanyl

Posterior Quadratus Lumborum Block

Patients scheduled for elective cesarean section under spinal anesthesia will receive bilateral ultrasound-guided posterior quadratus lumborum block.

Quadratus Lumborum II (QLB-II) Block

Intervention Type PROCEDURE

12.5 mg bupivacaine + 20 mcg fentanyl bilateral QLB block (posterior tip 2) 25 cc 0.25% bupivacaine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intrathecal Morphine (ITM)

morphine 100 mcg + 12.5 mg bupivacaine + 20 mcg fentanyl

Intervention Type PROCEDURE

Quadratus Lumborum II (QLB-II) Block

12.5 mg bupivacaine + 20 mcg fentanyl bilateral QLB block (posterior tip 2) 25 cc 0.25% bupivacaine

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant for at least 37 weeks
* Aged between 18 and 45
* ASA (American Society of Anesthesiologists) physical status score II
* Patient planned for elective cesarean section under spinal anesthesia
* Patient receiving QLB-II block or intrathecal morphine

Exclusion Criteria

* ASA score of III or IV.
* Planned cesarean section under general anesthesia.
* Requirement for conversion to general anesthesia after failed spinal anesthesia.
* Contraindication to spinal anesthesia and regional anesthesia techniques.
* BMI greater than 35 kg/m².
* History of opioid use disorder or opioid use for more than 4 weeks.
* Inability to assess pain scores.
* Pregnancies of less than 37 weeks gestation.
* History of allergy to local anesthetics and systemic opioids.
* Patient refusal

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No